Asthma exacerbations: pathogenesis, prevention, and treatment
JR Castillo, SP Peters, WW Busse - The Journal of Allergy and Clinical …, 2017 - Elsevier
Guideline-based management of asthma focuses on disease severity and choosing the
appropriate medical therapy to control symptoms and reduce the risk of exacerbations …
appropriate medical therapy to control symptoms and reduce the risk of exacerbations …
The effectiveness of the teach-back method on adherence and self-management in health education for people with chronic disease: a systematic review
Background Chronic diseases are increasing worldwide and have become a significant
burden to those affected by those diseases. Disease-specific education programs have …
burden to those affected by those diseases. Disease-specific education programs have …
Does monitoring goal progress promote goal attainment? A meta-analysis of the experimental evidence.
Control theory and other frameworks for understanding self-regulation suggest that
monitoring goal progress is a crucial process that intervenes between setting and attaining a …
monitoring goal progress is a crucial process that intervenes between setting and attaining a …
Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review
M Viswanathan, CE Golin, CD Jones… - Annals of internal …, 2012 - acpjournals.org
Background: Suboptimum medication adherence is common in the United States and leads
to serious negative health consequences but may respond to intervention. Purpose: To …
to serious negative health consequences but may respond to intervention. Purpose: To …
Interventional tools to improve medication adherence: review of literature
E Costa, A Giardini, M Savin, E Menditto… - Patient preference …, 2015 - Taylor & Francis
Medication adherence and persistence is recognized as a worldwide public health problem,
particularly important in the management of chronic diseases. Nonadherence to medical …
particularly important in the management of chronic diseases. Nonadherence to medical …
[HTML][HTML] Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD
MJ Mäkelä, V Backer, M Hedegaard, K Larsson - Respiratory medicine, 2013 - Elsevier
Suboptimal adherence to pharmacological treatment of asthma and chronic obstructive
pulmonary disease (COPD) has adverse effects on disease control and treatment costs. The …
pulmonary disease (COPD) has adverse effects on disease control and treatment costs. The …
Interventions for enhancing medication adherence
R Nieuwlaat, N Wilczynski, T Navarro… - Cochrane database …, 2014 - cochranelibrary.com
Background People who are prescribed self administered medications typically take only
about half their prescribed doses. Efforts to assist patients with adherence to medications …
about half their prescribed doses. Efforts to assist patients with adherence to medications …
Interventions to improve adherence to inhaled steroids for asthma
R Normansell, KM Kew… - Cochrane Database of …, 2017 - cochranelibrary.com
Background Despite its proven efficacy in improving symptoms and reducing exacerbations,
many patients with asthma are not fully adherent to their steroid inhaler. Suboptimal …
many patients with asthma are not fully adherent to their steroid inhaler. Suboptimal …
Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories …
Background Non-adherence to medications is prevalent across all medical conditions that
include ambulatory pharmacotherapy and is thus a major barrier to achieving the benefits of …
include ambulatory pharmacotherapy and is thus a major barrier to achieving the benefits of …
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
N Duru, MC Van Der Goes, JWG Jacobs… - Annals of the …, 2013 - ard.bmj.com
To develop recommendations for the management of medium to high-dose (ie,> 7.5 mg
but≤ 100 mg prednisone equivalent daily) systemic glucocorticoid (GC) therapy in …
but≤ 100 mg prednisone equivalent daily) systemic glucocorticoid (GC) therapy in …